14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.48 $5.48 Wednesday, 24th Apr 2024 QURE stock ended at $4.56. This is 4.00% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 6.70% from a day low at $4.48 to a day high of $4.78.
90 days $4.48 $6.85
52 weeks $4.48 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
Apr 24, 2024 $4.77 $4.78 $4.48 $4.56 565 569
Apr 23, 2024 $4.82 $4.90 $4.74 $4.75 314 023
Apr 22, 2024 $4.70 $4.87 $4.67 $4.82 377 899
Apr 19, 2024 $4.71 $4.75 $4.61 $4.67 503 901
Apr 18, 2024 $4.66 $4.76 $4.66 $4.71 438 697
Apr 17, 2024 $4.73 $4.77 $4.61 $4.67 513 102
Apr 16, 2024 $4.71 $4.80 $4.66 $4.70 419 990
Apr 15, 2024 $4.79 $4.83 $4.62 $4.74 536 278
Apr 12, 2024 $4.96 $5.03 $4.72 $4.78 1 217 390
Apr 11, 2024 $5.09 $5.16 $4.98 $5.03 520 238
Apr 10, 2024 $4.99 $5.06 $4.95 $5.02 963 783
Apr 09, 2024 $5.23 $5.31 $5.12 $5.20 470 660
Apr 08, 2024 $5.17 $5.22 $5.00 $5.20 527 251
Apr 05, 2024 $5.15 $5.24 $5.08 $5.15 513 841
Apr 04, 2024 $5.41 $5.48 $5.16 $5.20 425 508
Apr 03, 2024 $4.96 $5.33 $4.96 $5.32 599 387
Apr 02, 2024 $5.05 $5.12 $4.98 $4.98 748 089
Apr 01, 2024 $5.20 $5.22 $4.98 $5.21 838 492
Mar 28, 2024 $5.35 $5.40 $5.16 $5.20 758 410
Mar 27, 2024 $5.32 $5.45 $5.24 $5.41 589 656
Mar 26, 2024 $5.39 $5.42 $5.26 $5.32 446 346
Mar 25, 2024 $5.25 $5.44 $5.25 $5.35 441 902
Mar 22, 2024 $5.16 $5.31 $5.04 $5.28 518 774
Mar 21, 2024 $5.24 $5.26 $5.11 $5.19 660 474
Mar 20, 2024 $5.14 $5.27 $4.95 $5.23 594 741
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT